John M. Porter

Mr. Porter joined the Company in October 2008 and was appointed to the position of Senior Vice President. He is responsible for overall strategic planning and corporate development. His primary areas of focus are to advance the Company’s biotechnology initiatives in microgravity processing and commercialize advance technologies that have been developed in and around the space industry.

With over 10 years experience in the Life Science and Investment Banking industries, Mr. Porter provides valuable insights into the Company’s biotechnology, vaccine development, and pharmaceutical discovery programs. He also has a unique background in business development, strategic planning and corporate finance to augment the Company’s plans to commercialize various technologies that have been discovered via the space program.

Prior to joining the Company, Mr. Porter co-founded Arabella Securities, an investment banking firm that specialized in providing trading services and equity research on small-cap companies to institutional investors. He headed the Equity Research department, and published research on small companies in the Healthcare Technology sector. Arabella Securities subsequently merged with another broker/dealer in 2006 where Mr. Porter continued to lead the firm’s Healthcare investment banking practice. Mr. Porter previously served as Director of Business Development for Luminex Corporation (NASDAQ: LMNX), a leading developer of biological testing technologies for the Diagnostic and life sciences industries.

Mr. Porter has a Bachelor of Science in Chemistry from Hampden-Sydney College in Virginia. In addition, Mr. Porter earned a Master of Business Administration from the A.B. Freeman School of Business at Tulane University and holds a Master of Science in Physical Chemistry & Material Science from Tulane University in New Orleans. He has also passed the examinations for the Series 7, 24, 66, 86 and 87 designations by the Financial Industry Regulatory Authority (FINRA).